FOR IMMEDIATE RELEASE

Global Market for Protein Drugs Worth $160.1 Billion in 2013

Wellesley, Mass—According to a new technical market research report, PROTEIN DRUGS: GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES (BIO021C) from BCC Research, the global market for protein therapeutics was worth $86.8 billion in 2007 and an estimated $95.2 billion in 2008. This is expected to reach $160.1 billion in 2013 for a compound annual growth rate (CAGR) of 10.9%.

The market is broken down by type of protein drug and includes antibodies, cytokines, peptide hormones, vaccines, blood products, peptide antibiotics and enzymes. Of these, peptide hormones have the largest share of the market. Worth $26.1 billion in 2007, this segment is expected to increase to $27.9 billion in 2008 and $50.4 billion in 2013, for a CAGR of 12.6%.

The second largest share of the market belongs to cytokines, which generated $16.0 billion in 2007. This is expected to increase to $17.5 billion in 2008 and $26.8 billion in 2013, for a CAGR of 9.0%.

Blood products are the third largest market segment, worth $15.1 billion in 2007 and an estimated $15.9 billion in 2008. This should increase to $21.3 billion in 2013, for a CAGR of 6.1%.

Antibodies also have a significant share of the market. Worth $15.0 billion in 2007 and an estimated $18.1 billion in 2008. This segment should grow at a CAGR of 15.4% to reach $36.9 billion in 2013.

Although the drug development industry still focuses primarily on small molecules, in recent years protein and peptide therapeutics comprise a significant percent of the product line for most major pharmaceutical companies.

Protein drugs have received enormous attention from pharmaceutical companies due to a combination of their bioreactivity, specificity, safety and overall success rate. Yet there are still improvements to be made, especially with respect to their formulation and delivery method. Advances in protein drug delivery are certain to increase patient compliance and expand many drug markets.

Protein Drugs: Global Markets and Manufacturing Technologies ( BIO021C )
Target Date: October 2008    Price: $4850.00

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: editor@bccresearch.com as the source and publisher, along with report number, which can be found in the first paragraph of this release. Thank you.